From: Antiangiogenic therapy for breast cancer
Reference
Phase
Number of patients
Treatment
Response
Macaskill et al. [85]
II
30
Everolimus (14 days prior to surgery)
Reduced cell proliferation
Baselga et al. [86]
II (randomised)
270
Everolimus + letrozole
RR 68%
Letrozole
59%